By JESSICA DAMASSA, WTF HEALTH
Deena Shakir, Basic Associate at Lux Capital, shares her take available on the market state-of-play for healthcare innovation amid these “tumultuous” financial occasions. As an investor, Deena has been a passionate advocate for ladies and youngsters’s well being and her fund, Lux Capital, invests broadly in well being tech – pre-seed to pre-IPO, from virtual-first care supply companies like girls’s well being clinic, Maven, (on whose Board Deena sits after Lux co-led their $110M Sequence D) to well being tech infrastructure companies like Commure and Tendo and people working in AI, ML, and robotics.
We get into which kinds of rising well being companies Deena thinks are nonetheless “sizzling” regardless of the downturn, particularly speaking about what’s altering in girls’s well being together with present care gaps, well being IT infrastructure and its “second” this yr, and the way the alternatives in psychological well being investing are beginning look extra compelling on the diagnostic aspect of issues.
Total sentiment: Deena says, “As Enterprise Capital buyers we’ve got very long time horizons. We need to put money into issues and have a 10-year plus outlook, so it’s truly an unbelievable time to be doing early-stage investing.” However, what if you happen to’ve sailed previous your Sequence A? Nicely…tune in to seek out out what Deena has to say about her expertise with later-stage startups and those that thought they might have had an exit deliberate this yr.
